Acrisure Capital Management’s Abbott ABT Stock Holding History

Acrisure Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,369	Closed	-$341K	–	4
2023 Q1	$341K	Buy	+3,369	New	+$356K	0.35%	105

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Acrisure Capital Management's ABT Position: Q2 2023 in Review

Acrisure Capital Management sold out of Abbott (ABT) in Q2 2023, closing a stake of 3,369 shares — an estimated $341K sold.

Acrisure Capital Management first reported a position in ABT in Q1 2023 and held it in 1 quarter. The position peaked at $341K in Q1 2023. 2,737 funds tracked by Wall St. Rank hold ABT as of Q2 2023.

Acrisure Capital Management reported no remaining Abbott position as of Q2 2023 after selling out during the quarter.
Acrisure Capital Management sold 3,369 Abbott shares in Q2 2023, an estimated $341K.
Acrisure Capital Management first reported a position in Abbott in Q1 2023 and held it in 1 quarter.
Acrisure Capital Management's Abbott position peaked at $341K in Q1 2023.
2,737 funds tracked by Wall St. Rank held Abbott as of Q2 2023.

Based on Acrisure Capital Management's 13F filing for Q2 2023.